Literature DB >> 10932456

Optimizing adherence to pharmaceutical care plans.

G Nichols-English1, S Poirier.   

Abstract

Adherence to pharmacotherapy is essential to optimal therapeutic outcomes. The pivotal role of the pharmacist in optimizing adherence encompasses many actions: assessing the adherence problem, identifying predisposing factors, providing comprehensive counseling, and recommending specific adherence strategies targeted to the patient's needs. Patients who have chronic conditions, physical or cognitive impairments, or cultural backgrounds outside the mainstream may have special needs that should be addressed in the adherence plan. Pharmaceutical care plans also should take into account the patient's age, stage of life, and literacy level. Although a wide range of adherence aids and strategies are available, the key to success is to tailor the intervention to the individual patient and, when necessary, to combine interventions to optimize adherence.

Entities:  

Mesh:

Year:  2000        PMID: 10932456

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  24 in total

Review 1.  Issues of adherence to immunosuppressant therapy after solid-organ transplantation.

Authors:  Marie A Chisholm
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Using the transtheoretical model's stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting.

Authors:  Yara Arafat; Mohamed Izham Mohamed Ibrahim; Ahmed Awaisu; Stephen Colagiuri; Yaw Owusu; Donald E Morisky; Mudather AlHafiz; Ahmed Yousif
Journal:  Daru       Date:  2019-02-07       Impact factor: 3.117

3.  Treatment non-adherence among patients with poorly controlled type 2 diabetes in ambulatory care settings in southwestern Nigeria.

Authors:  Rasaq Adisa; Titilayo O Fakeye
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

4.  Low literacy impairs comprehension of prescription drug warning labels.

Authors:  Terry C Davis; Michael S Wolf; Pat F Bass; Mark Middlebrooks; Estela Kennen; David W Baker; Charles L Bennett; Ramon Durazo-Arvizu; Anna Bocchini; Stephanie Savory; Ruth M Parker
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

5.  Predictors of medication nonadherence differ among black and white patients with heart failure.

Authors:  Victoria Vaughan Dickson; George J Knafl; Barbara Riegel
Journal:  Res Nurs Health       Date:  2015-05-11       Impact factor: 2.228

6.  Associations Among Depressive Symptoms, Wellness, Patient Involvement, Provider Cultural Competency, and Treatment Nonadherence: A Pilot Study Among Community Patients Seen at a University Medical Center.

Authors:  Lisa M Hooper; Lauren E Huffman; John C Higginbotham; George C T Mugoya; Annie K Smith; Tia N Dumas
Journal:  Community Ment Health J       Date:  2017-04-05

7.  A Study of Medication Compliance in Geriatric Patients with Chronic Illnesses at a Tertiary Care Hospital.

Authors:  R Shruthi; R Jyothi; H P Pundarikaksha; G N Nagesh; T J Tushar
Journal:  J Clin Diagn Res       Date:  2016-12-01

8.  Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults : a randomized, open-label, two-period crossover, single-centre study.

Authors:  Mona Darwish; Edward T Hellriegel; Fang Xie
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

9.  Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.

Authors:  Anan S Jarab; Reham Almrayat; Salam Alqudah; Ekbal Thehairat; Tareq L Mukattash; Maher Khdour; Sharrel Pinto
Journal:  Int J Clin Pharm       Date:  2014-05-08

10.  Pharmacists' attitudes and perceived barriers to provision of adherence support in Australia.

Authors:  Sarab M Mansoor; Parisa Aslani; Ines Krass
Journal:  Int J Clin Pharm       Date:  2013-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.